Clindamycin Injection, Solution
Product Images NDC 71872-7192

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7192-1.pdp (71872 7192 1)

71872-7192-1.pdp (71872 7192 1)
This is a product description of Clindamycin Injection, USP, with a quantity of one vial per package containing 600 mg per 4mL (150 mg per mL) and the lot number and expiry date of the product. It is a sterile, nonpyrogenic solution that needs to be diluted before intravenous use, and for use in the muscle. The container has no natural rubber latex, and the package insert contains normal dosage information. It contains clindamycin phosphate equivalent to clindamycin, plus 0.5 mg disodium edetate and 9.45 mg benzyl alcohol as preservatives. It may contain sodium hydroxide and/or hydrochloric acid to adjust pH. It should be stored at 20° to 25°C (68°to 77°F) and not refrigerated. It is manufactured for SAGENT Pharmaceuticals in Schaumburg, IL (USA), but made in India. The product has been repackaged and distributed by Medical Purchasing Solutions, based in Scottsdale, AZ.*
FDA Label Image

Structural Formula (Cli04 0015 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.